Clinical Trial Update: Ph3b/4 Trial in Patients With Barth Syndrome [Phase 4]

View source ↗

Summary

Notes a Phase 3b/4 clinical trial in Barth Syndrome, sponsored by Stealth BioTherapeutics, that is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Barth Syndrome

Drugs mentioned

• Elamipretide (elamipretide)

Snippet

Sponsor: Stealth BioTherapeutics Inc. | Conditions: Barth Syndrome | Phase 4 | Status: NOT_YET_RECRUITING